Cytosorbents (CTSO) Return on Invested Capital (QoQ) (2017 - 2024)

Cytosorbents (CTSO) Return on Invested Capital (QoQ) (2017 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.44 Bn 175.14 Bn 6.27 Bn
2 Stryker 128.87 Bn 125.99 Bn 3.81 Bn
3 Medtronic 108.10 Bn 98.88 Bn 6.41 Bn
4 Boston Scientific 67.99 Bn 66.53 Bn 3.61 Bn
5 Edwards Lifesciences 48.22 Bn 44.55 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.15 Bn 750.30 Mn
7 GE HealthCare Technologies 28.02 Bn 25.74 Bn 1.98 Bn
8 Smith & Nephew 27.01 Bn 26.43 Bn -
9 Koninklijke Philips 23.74 Bn 20.62 Bn 2.07 Bn
10 Cytosorbents 22.27 Mn 17.47 Mn 6.13 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 1.00
Mar 31, 2024 8.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.00
Sep 30, 2020 1.00
Jun 30, 2020 1.00
Mar 31, 2020 1.00
Dec 31, 2019 1.00
Sep 30, 2019 2.00
Jun 30, 2019 5.00
Mar 31, 2019 -4.00
Dec 31, 2018 -4.00
Sep 30, 2018 -1.00
Jun 30, 2018 0.00
Mar 31, 2018 0.00
Dec 31, 2017 1.00
Sep 30, 2017 1.00
Jun 30, 2017 3.00
Mar 31, 2017 8.00